- Home
- ENS vs APLS Comparison
ENS vs APLS Comparison
Compare ENS & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENS
- APLS
- Stock Information
- Founded
- ENS 1991
- APLS 2009
- Country
- ENS United States
- APLS United States
- Employees
- ENS N/A
- APLS N/A
- Industry
- ENS Industrial Machinery/Components
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- ENS Technology
- APLS Health Care
- Exchange
- ENS Nasdaq
- APLS Nasdaq
- Market Cap
- ENS 3.7B
- APLS 3.3B
- IPO Year
- ENS N/A
- APLS 2017
- Fundamental
- Price
- ENS $93.07
- APLS $24.27
- Analyst Decision
- ENS Buy
- APLS Buy
- Analyst Count
- ENS 3
- APLS 18
- Target Price
- ENS $117.50
- APLS $45.53
- AVG Volume (30 Days)
- ENS 381.6K
- APLS 1.7M
- Earning Date
- ENS 05-21-2025
- APLS 05-06-2025
- Dividend Yield
- ENS 1.03%
- APLS N/A
- EPS Growth
- ENS 21.88
- APLS N/A
- EPS
- ENS 8.05
- APLS N/A
- Revenue
- ENS $3,553,458,000.00
- APLS $781,367,000.00
- Revenue This Year
- ENS $1.96
- APLS $12.95
- Revenue Next Year
- ENS $4.63
- APLS $21.35
- P/E Ratio
- ENS $11.77
- APLS N/A
- Revenue Growth
- ENS N/A
- APLS 97.02
- 52 Week Low
- ENS $88.50
- APLS $23.25
- 52 Week High
- ENS $112.53
- APLS $59.91
- Technical
- Relative Strength Index (RSI)
- ENS 36.66
- APLS 40.15
- Support Level
- ENS $94.66
- APLS $23.25
- Resistance Level
- ENS $99.52
- APLS $24.88
- Average True Range (ATR)
- ENS 2.20
- APLS 0.91
- MACD
- ENS -0.41
- APLS 0.11
- Stochastic Oscillator
- ENS 7.43
- APLS 38.35
About ENS EnerSys
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers worldwide. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.